Print ISSN:-
Online ISSN:-2582-1075
Original Article
Author Details :
Volume : 2, Issue : 4, Year : 2020
Article Page : 113-123
https://doi.org/10.18231/j.ijrimcr.2020.025
Abstract
Despite of worldwide efforts, the SARS CoV-2 (Covid-19) coronavirus pandemic is continuing. At present there is no medicine, vaccine which has evidence, so there is utmost need of clinical intervention by the oldest traditional health science that is Ayurveda. In Ayurveda text ‘Acharya charak’ has described in ‘viman sthan’ in ‘janpadodhawasan chapter’, about epidemic disease and its management, SARS CoV-2 can be correlated with the disease ‘tiwra Pinas’ which is ‘vata kapha sannipataj jwar’ which has similar symptoms like SARS CoV-2. Ayurvedic herbal medicine advised in this disease are ‘Aagneya in Guna’ most of the herbs are antiviral, antioxidants and immunity modulators which may help in preventive and therapeutic aspects by breaking virus, overall it may help to reduce mortality rate. In covid-19 other than Pneumonia; another cause may be disseminated intravascular coagulation that is thrombosis. The affected parts are lungs and terminally cardiac arrest, stroke and many other thromboembolic diseases, in this role of Ayurvedic herbal medicines may act as antiviral, antioxidant, anticoagulant, immunity modulator, also works in breathlessness and reduces mucus, reduces inflammation in respiratory tract as an anti-inflammatory effect & may reduce viral replication by breaking virus. Overall Ayurvedic herbal medicines may play important role in prophylaxis and therapeutic management of SARS CoV-2 (Covid-19) coronavirus.
Keywords: Ayurveda, ayurvedic herbal medicines, immunity modulators, prophylaxis, therapeutic management, SARS CoV-2 (Covid-19) coronavirus, traditional medicine Ayurveda, ‘Acharya charak’, ‘viman sthan’, ‘janapadodhawasan chapter’; ‘tiwra Pinas’; ‘vata kapha pradhan sannipataj jwar’; ‘aagneya in guna’.
How to cite : Bhadlikar D, Role of Ayurvedic Herbal Medicines and Ayurvedic Therapies in Prophylaxis and Therapeutic Management of SARS CoV-2 (Covid-19) Coronavirus. Int J Recent Innov Med Clin Res 2020;2(4):113-123
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.